Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-22-017397

SVP and General Counsel sold 1,569 shares at $12.01 ($18,844)

  • SVP and General Counsel acquired 61,779 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Taylor Stacy L SVP and General Counsel 2022-03-04 Grant or award +61,779 76,815 D
Taylor Stacy L SVP and General Counsel 2022-03-07 Sale −1,569 $12.01 $18,844 75,246 D
Derivatives
Taylor Stacy L SVP and General Counsel 2022-03-04 Grant or award · Stock Option (Right to Buy) +154,448 154,448 D
Open-market sales · 1,569 sh · avg $12.01 · $18,844
Loading xslF345X03/doc4.xml…